Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    1(33%)

    Phase Distribution

    Early Phase 1
    1
    33%
    Phase 2
    1
    33%
    Not Applicable
    1
    33%

    Phase Distribution

    1

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Early Phase 1First-in-human
    1(33.3%)
    Phase 2Efficacy & side effects
    1(33.3%)
    N/ANon-phased studies
    1(33.3%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 0 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Active(2)
    Other(1)

    Detailed Status

    Recruiting1
    unknown1
    Not yet recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    1
    Success Rate
    N/A
    Most Advanced
    Phase 2

    Trials by Phase

    Early Phase 11 (33.3%)
    Phase 21 (33.3%)
    N/A1 (33.3%)

    Trials by Status

    recruiting133%
    unknown133%
    not_yet_recruiting133%

    Recent Activity

    1 active trials
    Showing 3 of 3
    not_yet_recruitingphase_2

    Suprachoroidal Triamcinolone Acetonide Monotherapy in Treatment-naive Center Involving Diabetic Macular Edema

    NCT07870226
    recruitingearly_phase_1

    Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon

    NCT07145008
    unknownnot_applicable

    Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)

    NCT05496530

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT07870226Phase 2

    Suprachoroidal Triamcinolone Acetonide Monotherapy in Treatment-naive Center Involving Diabetic Macular Edema

    Not Yet Recruiting
    NCT07145008Early Phase 1

    Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon

    Recruiting
    NCT05496530Not Applicable

    Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)

    Unknown

    All 3 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    3